Intrinsic differences between authentic and cryptic 5′ splice sites

Nucleic Acids Research

Volumn 31, Issue 21, 2003, Pages 6321-6333

  Roca, Xavier ^a   Sachidanandam, Ravi ^a   Krainer, Adrian R ^a  

^a Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLOBIN; MESSENGER RNA;

CONTROLLED STUDY; DNA SEQUENCE; EXON; GENE FREQUENCY; GENE LOCATION; GENE MUTATION; GENE SEQUENCE; GENETIC CONSERVATION; HUMAN; IN VITRO STUDY; INTRON; MOLECULAR CLONING; PRIORITY JOURNAL; REVIEW; RNA SPLICING; SCORING SYSTEM; SEQUENCE DATABASE; STATISTICAL ANALYSIS;

ALTERNATIVE SPLICING; BASE SEQUENCE; EXONS; GLOBINS; HUMANS; HYDROXYMETHYLBILANE SYNTHASE; INTRONS; MOLECULAR SEQUENCE DATA; MUTATION; RNA PRECURSORS; RNA SPLICE SITES; RNA, MESSENGER; TEMPLATES, GENETIC;

EID: 0344011094     PISSN: 03051048     EISSN: None     Source Type: Journal    
DOI: 10.1093/nar/gkg830     Document Type: Review

References (105)

1. Sun,H. and Chasin,L.A. (2000) Multiple splicing defects in an intronic false exon. Mol. Cell. Biol., 20, 6414-6425.
2. Horowitz,D.S. and Krainer,A.R. (1994) Mechanisms for selecting 5′ splice sites in mammalian pre-mRNA splicing. Trends Genet., 10, 100-106.
3. Zhuang,Y. and Weiner,A.M. (1986) A compensatory base change in U1 snRNA suppresses a 5′ splice site mutation. Cell, 46, 827-835.
4. Siliciano,P.G. and Guthrie,C. (1988) 5′ splice site selection in yeast: genetic alterations in base-pairing with U1 reveal additional requirements. Genes Dev., 2, 1258-1267.
5. Seraphin,B., Kretzner,L. and Rosbash,M. (1988) A U1 snRNA:pre-mRNA base pairing interaction is required early in yeast spliceosome assembly but does not uniquely define the 5′ cleavage site. EMBO J., 7, 2533-2538.
6. Crispino,J.D., Blencowe,B.J. and Sharp,P.A. (1994) Complementation by SR proteins of pre-mRNA splicing reactions depleted of U1 snRNP. Science, 265, 1866-1869.
7. Crispino,J. and Sharp,P.A. (1995) U6 snRNA:pre-mRNA interaction can be rate-limiting for U1-independent splicing. Genes Dev., 9, 2314-2323.
8. Tarn,W. and Steitz,J. (1994) SR proteins can compensate for the loss of U1 snRNP functions in vitro. Genes Dev., 8, 2704-2717.
9. Lund,M. and Kjems,J. (2002) Defining a 5′ splice site by functional selection in the presence and absence of U1 snRNA 5′ end. RNA, 8, 166-179.
10. Du,H. and Rosbash,M. (2001) Yeast U1 snRNP-pre-mRNA complex formation without U1 snRNA-pre-mRNA base pairing. RNA, 7, 133-142.
11. Du,H. and Rosbash,M. (2002) The U1 snRNP protein U1C recognizes the 5′ splice site in the absence of base pairing. Nature, 419, 86-90.
12. Eperon,I.C., Ireland,D.C., Smith,R.A., Mayeda,A. and Krainer,A.R. (1993) Pathways for selection of 5′ splice sites by U1 snRNPs and SF2/ASF. EMBO J., 12, 3607-3617.
13. Wassarman,D.A. and Steitz,J.A. (1992) Interactions of small nuclear RNA's with precursor messenger RNA during in vitro splicing. Science, 257, 1918-1925.
14. Brackenridge,S., Wilkie,A.O. and Screaton,G.R. (2003) Efficient use of a 'dead-end' GA 5′ splice site in the human fibroblast growth factor receptor genes. EMBO J., 22, 1620-1631.
15. Hwang,D.Y. and Cohen,J.B. (1996) U1 snRNA promotes the selection of nearby 5′ splice sites by U6 snRNA in mammalian cells. Genes Dev., 10, 338-350.
16. Treisman,R., Orkin,S.H. and Maniatis,T. (1983) Specific transcription and RNA splicing defects in five cloned beta-thalassaemia genes. Nature, 302, 591-596.
17. Chabot,B. and Steitz,J.A. (1987) Recognition of mutant and cryptic 5′ splice sites by the U1 small nuclear ribonucleoprotein in vitro. Mol. Cell. Biol., 7, 698-707.
18. Nelson,K.K. and Green,M.R. (1990) Mechanism for cryptic splice site activation during pre-mRNA splicing. Proc. Natl Acad. Sci. USA, 87, 6253-6257.
19. Cáceres,J.F., Stamm,S., Helfman,D.M. and Krainer,A.R. (1994) Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors. Science, 265, 1706-1709.
20. Krainer,A.R., Conway,G.C. and Kozak,D. (1990) The essential pre-mRNA splicing factor SF2 influences 5′ splice site selection by activating proximal sites. Cell, 62, 35-42.
21. Mayeda,A. and Krainer,A.R. (1992) Regulation of alternative pre-mRNA splicing by hnRNP A1 and splicing factor SF2. Cell, 68, 365-375.
22. Domenjoud,L., Kister,L., Gallinaro,H. and Jacob,M. (1993) Selection between a natural and a cryptic 5′ splice site: a kinetic study of the effect of upstream exon sequences. Gene Expr., 3, 83-94.
23. Roller,A., Hoffman,D. and Zahler,A. (2000) The allele-specific suppressor sup-39 alters use of cryptic splice sites in Caenorhabditis elegans. Genetics, 154, 1169-1179.
24. Run,J.Q., Steven,R., Hung,M.S., van Weeghel,R., Culotti,J.G. and Way,J.C. (1996) Suppressors of the unc-73 gene of Caenorhabditis elegans. Genetics, 143, 225-236.
25. Newman,A. and Norman,C. (1992) U5 snRNA interacts with exon sequences at 5′ and 3′ splice sites. Cell, 68, 743-754.
26. Kandels-Lewis,S. and Seraphin,B. (1993) Involvement of U6 snRNA in 5′ splice site selection. Science, 262, 2035-2039.
27. Alvarez,C.J. and Wise,J.A. (2001) Activation of a cryptic 5′ splice site by U1 snRNA. RNA, 7, 342-350.
28. Lear,A.L., Eperon,L.P., Wheatley,I.M. and Eperon,I.C. (1990) Hierarchy for 5′ splice site preference determined in vivo. J. Mol. Biol., 211, 103-115.
29. Krawczak,M., Reiss,J. and Cooper,D.N. (1992) The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum. Genet., 90, 41-54.
30. Ars,E., Serra,E., Garcia,J., Kruyer,H., Gaona,A., Lazaro,C. and Estivill,X. (2000) Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1. Hum. Mol. Genet. 9, 237-247.
31. Teraoka,S.N., Telatar,M., Becker-Catania,S., Liang,T., Onengut,S., Tolun,A., Chessa,L., Sanal,O., Bernatowska,E., Gatti,R.A. and Concannon,P. (1999) Splicing defects in the ataxia-telangiectasia gene, ATM: underlying mutations and consequences. Am. J. Hum. Genet., 64, 1617-1631.
32. Nakai,K. and Sakamoto,H. (1994) Construction of a novel database containing aberrant splicing mutations of mammalian genes. Gene, 141, 171-177.
33. Lee,C., Atanelov,L., Modrek,B. and Xing,Y. (2003) ASAP: the Alternative Splicing Annotation Project. Nucleic Acids Res., 31, 101-105.
34. Senapathy,P., Shapiro,M.B. and Harris,N.L. (1990) Splice junctions, branch point sites and exons: sequence statistics, identification and applications to genome project. Methods Enzymol., 183, 252-278.
35. Shapiro,M.B. and Senapathy,P. (1987) RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. Nucleic Acids Res., 15, 7155-7174.
36. Serra,M.J. and Turner,D.H. (1995) Predicting thermodynamic properties of RNA. Methods Enzymol., 259, 242-261.
37. Mayeda,A. and Krainer,A.R. (1999) Mammalian in vitro splicing assays. Methods Mol. Biol., 118, 315-321.
38. Mayeda,A. and Krainer,A.R. (1999) Preparation of HeLa cell nuclear and cytosolic S100 extracts for in vitro splicing. Methods Mol. Biol., 118, 309-314.
39. Delfau,M.H., Picat,C., De Rooij,F., Voortman,G., Deybach,J.C., Nordmann,Y. and Grandchamp,B. (1991) Molecular heterogeneity of acute intermittent porphyria: identification of four additional mutations resulting in the CRIM-negative subtype of the disease. Am. J. Hum. Genet., 49, 421-428.
40. Sakuntabhai,A., Hammami-Hauasli,N., Bodemer,C., Rochat,A., Prost,C., Barrandon,Y., de Prost,Y., Lathrop,M., Wojnarowska,F., Bruckner-Tuderman,L. and Hovnanian,A. (1998) Deletions within COL7A1 exons distant from consensus splice sites alter splicing and produce shortened polypeptides in dominant dystrophic epidermolysis bullosa. Am. J. Hum. Genet., 63, 737-748.
41. Colgin,L.M., Hackmann,A.F. and Monnat,R.J.,Jr (1999) Different somatic and germline HPRT1 mutations promote use of a common, cryptic intron 1 splice site. Hum. Mutat., 14, 92.
42. MacLeod,J.N., Liebhaber,S.A., MacGillivray,M.H. and Cooke,N.E. (1991) Identification of a splice-site mutation in the human growth hormone-variant gene. Am. J. Hum. Genet., 48, 1168-1174.
43. Berget,S. (1995) Exon recognition in vertebrate splicing. J. Biol. Chem., 270, 2411-2414.
44. Li,B., Wachtel,C., Miriami,E., Yahalom,G., Friedlander,G., Sharon,G., Sperling,R. and Sperling,J. (2002) Stop codons affect 5′ splice site selection by surveillance of splicing. Proc. Natl Acad. Sci. USA, 99, 5277-5282.
45. Zhang,X., Lee,J. and Chasin,L.A. (2003) The effect of nonsense codons on splicing: a genomic analysis. RNA, 9, 637-639.
46. Gardella,R., Belletti,L., Zoppi,N., Marini,D., Barlati,S. and Colombi,M. (1996) Identification of two splicing mutations in the collagen type VII gene (COL7A1) of a patient affected by the localisata variant of recessive dystrophic epidermolysis bullosa. Am. J. Hum. Genet., 59, 292-300.
47. Brunak,S., Engelbrecht,J. and Knudsen,S. (1991) Prediction of human mRNA donor and acceptor sites from the DNA sequence. J. Mol. Biol., 220, 49-65.
48. Yeo,G. and Burge,C.B. (2003) Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals. In Miller,W., Vingron,M., Istrail,S., Pevzner,P. and Waterman,M. (eds), Proceedings of the 7th Annual International Conference on Computational Molecular Biology (RECOMB03). ACM Press, New York, NY, pp. 322-331.
49. Zielenski,J., Bozon,D., Markiewicz,D., Aubin,G., Simard,F., Rommens,J.M. and Tsui,L.C. (1993) Analysis of CFTR transcripts in nasal epithelial cells and lymphoblasts of a cystic fibrosis patient with 621 + 1G→T and 711 + 1G→T mutations. Hum. Mol. Genet., 2, 683-687.
50. Kuivaniemi,H., Kontusaari,S., Tromp,G., Zhao,M.J., Sabol,C. and Prockop,D.J. (1990) Identical G+1 to A mutations in three different introns of the type III procollagen gene (COL3A1) produce different patterns of RNA splicing in three variants of Ehlers-Danlos syndrome. IV. An explanation for exon skipping some mutations and not others. J. Biol. Chem., 265, 12067-12074.
51. Pinotti,M., Toso,R., Redaelli,R., Berrettini,M., Marchetti,G. and Bernardi,F. (1998) Molecular mechanisms of FVII deficiency: expression of mutations clustered in the IVS7 donor splice site of factor VII gene. Blood, 92, 1646-1651.
52. Furihata,K., Drousiotou,A., Hara,Y., Christopoulos,G., Stylianidou,G., Anastasiadou,V., Ueno,I. and Ioannou,P. (1999) Novel splice site mutation at IVS8 nt 5 of HEXB responsible for a Greek-Cypriot case of Sandhoff disease. Hum. Mutat., 13, 38-43.
53. Maruyama,T., Miyake,Y., Tajima,S., Funahashi,T., Matsuzawa,Y. and Yamamoto,A. (1995) A single point mutation in the splice donor site of the low-density-lipoprotein-receptor gene produces intron read-through, exon-skipped and cryptic-site-utilized transcripts. Eur. J. Biochem., 232, 700-705.
54. Gotoda,T., Yamada,N., Murase,T., Inaba,T., Ishibashi,S., Shimano,H., Koga,S., Yazaki,Y., Furuichi,Y. and Takaku,F. (1991) Occurrence of multiple aberrantly spliced mRNAs upon a donor splice site mutation that causes familial lipoprotein lipase deficiency. J. Biol. Chem., 266, 24757-24762.
55. Robberson,B.L., Cote,G.J. and Berget,S.M. (1990) Exon definition may facilitate splice site selection in RNAs with multiple exons. Mol. Cell. Biol. 10, 84-94.
56. Maquat,L.E. (2000) Nonsense-mediated RNA decay in mammalian cells: a splicing-dependent means to down-regulate the levels of mRNAs that prematurely terminate translation. In Sonenberg,N., Hershey,J.W.B. and Mathews,M.B. (eds), Translational Control of Gene Expression. Cold Spring Harbor Press, Cold Spring Harbor, New York, NY, pp. 849-868.
57. Danckwardt,S., Neu-Yilik,G., Thermann,R., Frede,U., Hentze,M.W. and Kulozik,A.E. (2002) Abnormally spliced beta-globin mRNAs: a single point mutation generates transcripts sensitive and insensitive to nonsense-mediated mRNA decay. Blood, 99, 1811-1816.
58. Cartegni,L., Chew,S.L. and Krainer,A.R. (2002) Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nature Rev. Genet., 3, 285-298.
59. McCullough,A. and Berget,S. (1997) G triplets located throughout a class of small vertebrate introns enforce intron borders and regulate splice site selection. Mol. Cell. Biol., 17, 4562-4571.
60. Ladd,A.N. and Cooper,T.A. (2002) Finding signals that regulate alternative splicing in the post-genomic era. Genome Biol., 3, 0008.1-0008.16 (reviews).
61. Reed,R. (1996) Initial splice-site recognition and pairing during pre-mRNA splicing. Curr. Opin. Genet. Dev., 6, 215-220.
62. Krainer,A.R., Maniatis,T., Ruskin,B. and Green,M.R. (1984) Normal and mutant human beta-globin pre-mRNAs are faithfully and efficiently spliced in vitro. Cell, 36, 993-1005.
63. Cunningham,S.A., Else,A.J., Potter,B.V. and Eperon,I.C. (1991) Influences of separation and adjacent sequences on the use of alternative 5′ splice sites. J. Mol. Biol., 217, 265-281.
64. Dominski,Z. and Kole,R. (1993) Restoration of correct splicing in thalassemic pre-mRNA by antisense oligonucleotides. Proc. Natl Acad. Sci. USA, 90, 8673-8677.
65. Guimaraes,C.P., Lemos,M., Menezes,I., Coelho,T., Sa-Miranda,C. and Azevedo,J. (2001) Characterisation of two mutations in the ABCD1 gene leading to low levels of normal ALDP. Hum. Genet., 109, 616-622.
66. Nemeth-Slany,A., Talmud,P., Grundy,S.M. and Patel,S.B. (1997) Activation of a cryptic splice-site in intron 24 leads to the formation of apolipoprotein B-27.6. Atherosclerosis, 133, 163-170.
67. Ris-Stalpers,C., Kuiper,G.G., Faber,P.W., Schweikert,H.U., van Rooij,H.C., Zegers,N.D., Hodgins,M.B., Degenhart,H.J., Trapman,J. and Brinkmann,A.O. (1990) Aberrant splicing of androgen receptor mRNA results in synthesis of a nonfunctional receptor protein in a patient with androgen insensitivity. Proc. Natl Acad. Sci. USA, 87, 7866-7870.
68. Vega,A., Campos,B., Bressac-De-Paillerets,B., Bond,P.M., Janin,N., Douglas,F.S., Domenech,M., Baena,M., Pericay,C., Alonso,C., Carracedo,A., Baiget,M. and Diez,O. (2001) The R71G BRCA1 is a founder Spanish mutation and leads to aberrant splicing of the transcript. Hum. Mutat., 17, 520-521.
69. Scholl,T., Pyne,M.T., Russo,D. and Ward,B.E. (1999) BRCA1 IVS16+6T→C is a deleterious mutation that creates an aberrant transcript by activating a cryptic splice donor site. Am. J. Med. Genet., 85, 113-116.
70. Jones,C.T., McIntosh,I., Keston,M., Ferguson,A. and Brock,D.J. (1992) Three novel mutations in the cystic fibrosis gene detected by chemical cleavage: analysis of variant splicing and a nonsense mutation. Hum. Mol. Genet., 1, 11-17.
71. Wang,Q., Forlino,A. and Marini,J.C. (1996) Alternative splicing in COL1A1 mRNA leads to a partial null allele and two in-frame forms with structural defects in non-lethal osteogenesis imperfecta. J. Biol. Chem., 271, 28617-28623.
72. Schwarze,U., Starman,B.J. and Byers,P.H. (1999) Redefinition of exon 7 in the COL1A1 gene of type I collagen by an intron 8 splice-donor-site mutation in a form of osteogenesis imperfecta: influence of intron splice order on outcome of splice-site mutation. Am. J. Hum. Genet., 65, 336-344.
73. Bateman,J.F., Chan,D., Moeller,I., Hannagan,M. and Cole,W.G. (1994) A 5′ splice site mutation affecting the pre-mRNA splicing of two upstream exons in the collagen COL1A1 gene. Exon 8 skipping and altered definition of exon 7 generates truncated pro alpha 1(I) chains with a non-collagenous insertion destabilizing the triple helix. Biochem. J., 302, 729-735.
74. Vanegas,O.C., Zhang,R.Z., Sabatelli,P., Lattanzi,G., Bencivenga,P., Giusti,B., Columbaro,M., Chu,M.L., Merlini,L. and Pepe,G. (2002) Novel COL6A1 splicing mutation in a family affected by mild Bethlem myopathy. Muscle Nerve, 25, 513-519.
75. Botto,M., Fong,K.Y., So,A.K., Rudge,A. and Walport,M.J. (1990) Molecular basis of hereditary C3 deficiency. J. Clin. Invest., 86, 1158-1163.
76. Harada,N., Ogawa,H., Shozu,M., Yamada,K., Suhara,K., Nishida,E. and Takagi,Y. (1992) Biochemical and molecular genetic analyses on placental aromatase (P-450AROM) deficiency. J. Biol. Chem., 267, 4781-4785.
77. Chen,W., Kubota,S., Ujike,H., Ishihara,T. and Seyama,Y. (1998) A novel Arg362Ser mutation in the sterol 27-hydroxylase gene (CYP27): its effects on pre-mRNA splicing and enzyme activity. Biochemistry, 37, 15050-15056.
78. Roest,P.A., Bout,M., van der Tuijn,A.C., Ginjaar,I.B., Bakker,E., Hogervorst,F.B., van Ommen,G.J. and den Dunnen,J.T. (1996) Splicing mutations in DMD/BMD detected by RT-PCR/PTT: detection of a 19AA insertion in the cysteine rich domain of dystrophin compatible with BMD. J. Med Genet., 33, 935-939.
79. Wilton,S.D., Chandler,D.C., Kakulas,B.A. and Laing,N.G. (1994) Identification of a point mutation and germinal mosaicism in a Duchenne muscular dystrophy family. Hum. Mutat., 3, 133-140.
80. Hahn,S.H., Krasnewich,D., Brantly,M., Kvittingen,E.A. and Gahl,W.A. (1995) Heterozygosity for an exon 12 splicing mutation and a W234G missense mutation in an American child with chronic tyrosinemia type 1. Hum. Mutat., 6, 66-73.
81. Hutchinson,S., Wordsworth,B.P. and Handford,P.A. (2001) Marfan syndrome caused by a mutation in FBN1 that gives rise to cryptic splicing and a 33 nucleotide insertion in the coding sequence. Hum. Genet. 109, 416-420.
82. Schrijver,I., Koerper,M.A., Jones,C.D. and Zehnder,J.L. (2002) Homozygous factor V splice site mutation associated with severe factor V deficiency. Blood, 99, 3063-3065.
83. Attanasio,C., de Moerloose,P., Antonarakis,S.E., Morris,M.A. and Neerman-Arbez,M. (2001) Activation of multiple cryptic donor splice sites by the common congenital afibrinogenemia mutation, FGA IVS4 + I G→T. Blood, 97, 1879-1881.
84. Sun,F., Knebelmann,B., Pueyo,M.E., Zouali,H., Lesage,S., Vaxillaire,M., Passa,P., Cohen,D., Velho,G., Antignac,C. et al. (1993) Deletion of the donor splice site of intron 4 in the glucokinase gene causes maturity-onset diabetes of the young. J. Clin. Invest., 92, 1174-1180.
85. Felber,B.K., Orkin,S.H. and Hamer,D.H. (1982) Abnormal RNA splicing causes one form of alpha thalassemia. Cell, 29, 895-902.
86. Akli,S., Chelly,J., Kahn,A. and Poenaru,L. (1993) A null allele frequent in non-Jewish Tay-Sachs patients. Hum. Genet., 90, 614-620.
87. Buesa,C., Pie,J., Barcelo,A., Casals,N., Mascaro,C., Casale,C.H., Haro,D., Duran,M., Smeitink,J.A. and Hegardt,F.G. (1996) Aberrantly spliced mRNAs of the 3-hydroxy-3-methylglutaryl coenzyme A lyase (HL) gene with a donor splice-site point mutation produce hereditary HL deficiency. J. Lipid Res., 37, 2420-2432.
88. Hunter,T.C., Melancon,S.B., Dallaire,L., Taft,S., Skopek,T.R., Albertini,R.J. and O'Neill,J.P. (1996) Germinal HPRT splice donor site mutation results in multiple RNA splicing products in T-lymphocyte cultures. Somat. Cell Mol. Genet., 22, 145-150.
89. Bunge,S., Steglich,C., Zuther,C., Beck,M., Morris,C.P., Schwinger,E., Schinzel,A., Hopwood,J.J. and Gal,A. (1993) Iduronate-2-sulfatase gene mutations in 16 patients with mucopolysaccharidosis type II (Hunter syndrome). Hum. Mol. Genet., 2, 1871-1875.
90. Matsuura,S., Kishi,F., Tsukahara,M., Nunoi,H., Matsuda,I., Kobayashi,K. and Kajii,T. (1992) Leukocyte adhesion deficiency: identification of novel mutations in two Japanese patients with a severe form. Biochem. Biophys. Res. Commun., 184, 1460-1467.
91. Jin,Y., Dietz,H.C., Nurden,A. and Bray,P.F. (1993) Single-strand conformation polymorphism analysis is a rapid and effective method for the identification of mutations and polymorphisms in the gene for glycoprotein IIIa. Blood, 82, 2281-2288.
92. Rugg,E.L., Rachet-Prehu,M.O., Rochat,A., Barrandon,Y., Goossens,M., Lane,E.B. and Hovnanian,A. (1999) Donor splice site mutation in keratin 5 causes in-frame removal of 22 amino acids of H1 and 1A rod domains in Dowling-Meara epidermolysis bullosa simplex. Eur. J. Hum. Genet., 7, 293-300.
93. Goyette,P., Frosst,P., Rosenblatt,D.S. and Rozen,R. (1995) Seven novel mutations in the methylenetetrahydrofolate reductase gene and genotype/phenotype correlations in severe methylenetetrahydrofolate reductase deficiency. Am. J. Hum. Genet., 56, 1052-1059.
94. Jacoby,L.B., MacCollin,M., Barone,R., Ramesh,V. and Gusella,J.F. (1996) Frequency and distribution of NF2 mutations in schwannomas. Genes Chromosomes Cancer, 17, 45-55.
95. Mustajoki,S., Pihlaja,H., Ahola,H., Petersen,N.E., Mustajoki,P. and Kauppinen,R. (1998) Three splicing defects, an insertion and two missense mutations responsible for acute intermittent porphyria. Hum. Genet., 102, 541-548.
96. Tsujino,S., Tonin,P., Shanske,S., Nohria,V., Boustany,R.M., Lewis,D., Chen,Y.T. and DiMauro,S. (1994) A splice junction mutation in a new myopathic variant of phosphoglycerate kinase deficiency (PGK North Carolina). Ann. Neurol., 35, 349-353.
97. Peral,B., Gamble,V., San Millan,J.L., Strong,C., Sloane-Stanley,J., Moreno,F. and Harris,P.C. (1995) Splicing mutations of the polycystic kidney disease 1 (PKD1) gene induced by intronic deletion. Hum. Mol. Genet., 4, 569-574.
98. Celebi,J.T., Wanner,M., Ping,X.L., Zhang,H. and Peacocke,M. (2000) Association of splicing defects in PTEN leading to exon skipping or partial intron retention in Cowden syndrome. Hum. Genet., 107, 234-238.
99. Tsujino,S., Shanske,S., Nonaka,I., Eto,Y., Mendell,J.R., Fenichel,G.M. and DiMauro,S. (1994) Three new mutations in patients with myophosphorylase deficiency (McArdle disease). Am. J. Hum. Genet., 54, 44-52.
100. Dry,K.L., Manson,F.D., Lennon,A., Bergen,A.A., Van Dorp,D.B. and Wright,A.F. (1999) Identification of a 5′ splice site mutation in the RPGR gene in a family with X-linked retinitis pigmentosa (RP3). Hum. Mutat., 13, 141-145.
101. Laubach,V.E., Ryan,W.J. and Brantly,M. (1993) Characterization of a human alpha 1-antitrypsin null allele involving aberrant mRNA splicing. Hum. Mol. Genet., 2, 1001-1005.
102. Ishioka,C., Sato,T., Gamoh,M., Suzuki,T., Shibata,H., Kanamaru,R., Wakui,A. and Yamazaki,T. (1991) Mutations of the P53 gene, including an intronic point mutation, in colorectal tumors. Biochem. Biophys. Res. Commun., 177, 901-906.
103. Sakai,E. and Tsuchida,N. (1992) Most human squamous cell carcinomas in the oral cavity contain mutated p53 tumor-suppressor genes. Oncogene, 7, 927-933.
104. vanBakel,I., Sepp,T., Ward,S., Yates,J.R. and Green,A.J. (1997) Mutations in the TSC2 gene: analysis of the complete coding sequence using the protein truncation test (PTT). Hum. Mol. Genet., 6, 1409-1414.
105. Gantla,S., Bakker,C.T., Deocharan,B., Thummala,N.R., Zweiner,J., Sinaasappel,M., Roy Chowdhury,J., Bosma,P.J. and Roy Chowdhury,N. (1998) Splice-site mutations: a novel genetic mechanism of Crigler-Najjar syndrome type 1. Am. J. Hum. Genet., 62, 585-592.